ALZHEIMERS DISEASE
Clinical trials for ALZHEIMERS DISEASE explained in plain language.
Never miss a new study
Get alerted when new ALZHEIMERS DISEASE trials appear
Sign up with your email to follow new studies for ALZHEIMERS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gum treatment may help fight Alzheimer's, small trial hints
Disease control ENROLLING_BY_INVITATIONThis study tests whether treating severe gum disease can slow down Alzheimer's disease. Researchers will give 26 people with both conditions deep dental cleaning, extractions if needed, and oral hygiene training. Over 24 months, they will track memory, thinking skills, and brain …
Matched conditions: ALZHEIMERS DISEASE
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Liege • Aim: Disease control
Last updated Jun 23, 2026 11:57 UTC
-
New Alzheimer's drug aims to clear brain plaques
Disease control OngoingThis study tests an experimental drug called RO7126209 (Trontinemab) in people with early to moderate Alzheimer's disease. The drug is given by IV infusion and aims to reduce amyloid plaques in the brain, a hallmark of Alzheimer's. About 241 participants will receive either the d…
Matched conditions: ALZHEIMERS DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 23, 2026 11:55 UTC
-
Could a drug combo delay genetic Alzheimer's?
Disease control OngoingThis study tests whether a new drug, E2814, given alongside lecanemab, can slow the progression of Alzheimer's disease in people who carry a genetic mutation that causes the disease. About 197 adults aged 18-80 with mild symptoms or no symptoms will receive either the drug or a p…
Matched conditions: ALZHEIMERS DISEASE
Phase: PHASE2, PHASE3 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 22, 2026 12:03 UTC
-
Can new drugs delay inherited Alzheimer's? major trial underway
Disease control OngoingThis study tests whether experimental drugs can slow down memory and thinking problems in people who have a gene mutation that causes Alzheimer's disease. About 490 adults aged 18-80 with this genetic risk are taking either a study drug or a placebo. The goal is to see if the dru…
Matched conditions: ALZHEIMERS DISEASE
Phase: PHASE2, PHASE3 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 18, 2026 11:51 UTC
-
Blood test aimed to speed up Alzheimer's diagnosis, but study was canceled
Knowledge-focused TerminatedThis study planned to see if using a special blood test (PrecivityAD2) could help doctors diagnose Alzheimer's disease or other dementias more quickly. It was designed for veterans and people in other closed healthcare systems who had memory problems. However, the study was withd…
Matched conditions: ALZHEIMERS DISEASE
Phase: NA • Sponsor: C2N Diagnostics • Aim: Knowledge-focused
Last updated Jun 18, 2026 11:49 UTC